Breast Biopsy Market to Reach $1.08 Bn, Globally, by 2030

 Allied Market Research published a report, titled, "Breast Biopsy Market by Product (Vacuum Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy), by Image Guided Technology (Mri Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Ct Guided Biopsy, Other Image Guided Breast Biopsy), by End User (Hospitals And Clinics, Diagnostic Centers): Global Opportunity Analysis and Industry Forecast, 2020-2030." According to the report, the global breast biopsy industry was estimated at $658.17 million in 2020, and is anticipated to hit $1.08 billion by 2030, registering a CAGR of 5.1% from 2021 to 2030.

For Right Perspective, Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/1067 

Drivers, restraints, and opportunities-

Increased sensitivity of women to mammary cancer in all countries, as well as awareness campaigns and screenings done in their favor drive the growth of the global breast biopsy market. On the other hand, incidences of adverse effects and infections after the biopsy restrain the growth to some extent. However, several government initiatives taken toward the development of diagnostic technologies are expected to create lucrative opportunities in the industry.

Covid-19 scenario-

  • Due to the ongoing lockdowns in several nations to prevent the spread of the Covid-19 virus, especially during the initial period, hospitals, clinics, and diagnostic facilities were unable to deliver biopsy services. This, in turn, impacted the breast biopsy market negatively.
  • Also, the pandemic led to a steep decline in the number of breast cancer check-ups. However, the market has already started recovering and is projected to get back on track soon.

The core needle biopsy segment to dominate by 2030-

On the basis of product, the core needle biopsy segment accounted for the highest market share in 2020, generating more than half of the global breast biopsy market. Surge in breast cancer has created a demand for precise diagnostic technology which has eventually resulted in the growth of the core needle biopsy procedure. The vacuum assisted biopsy segment, however, is anticipated to cite the fastest CAGR of 6.4% from 2021 to 2030.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/1067

The hospitals and clinics segment to maintain its lion's share-

On the basis of end use type, the hospitals & clinics segment generated the highest share in 2020, holding more than half of the global breast biopsy market. The diagnostic centers segment, on the other hand, is expected to cite the fastest CAGR of 6.0% from 2021 to 2030. This is attributed to the emergence of prioritizing imaging technology for breast cancer detection.

North America garnered the highest share in 2020-

On the basis of region, North America contributed to the major market share in terms of revenue 2020, holding more than two-fifths of the global breast biopsy market. Rise in cancer cases and steps undertaken by government to provide facilities for early diagnosis of cancer drive the market growth in the region. The Asia-Pacific region, simultaneously, is projected to cite the fastest CAGR of 7.1% from 2021 to 2030, due to surge in awareness and technological advancements in the breast healthcare sector.

Key players in the industry-

  • Intact Medical Corporation
  • Galini SRL
  • Hologic Inc.
  • Ethicon Endo Surgery
  • Becton and Dickinson Company
  • Encapsule medical Devices LLC.
  • Leica Biosystems Nussloch GmbH
  • C. R. Bard, Inc.
  • Argon Medical Devices
  • Cook Medical Incorporated

Comments

Post a Comment

Popular posts from this blog

$1,082.44+ Million Breast Biopsy Market key highlights driving the industry CAGR of 5.1% Forecast, 2024-2030

Image
  The global  breast biopsy market , valued at $658.17 million in 2020, is projected to reach $1,082.44 million by 2030, growing at a compound annual growth rate (CAGR) of 5.1%. As breast biopsies play a crucial role in diagnosing breast cancer, advancements in technology, and rising awareness, the market is experiencing steady growth. Below are some of the key highlights driving the industry: 𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:  https://www.alliedmarketresearch.com/request-sample/1067 1. Breast Biopsy: A Diagnostic Tool Breast biopsies are essential for diagnosing breast cancer and identifying other conditions through physical examinations. The most common method is fine needle aspiration biopsy (FNAB), a minimally invasive procedure that leaves no scarring. Additionally, ultrasound-guided biopsies use real-time imaging to locate tissue, while stereotactic mammography uses images from various angles to precisely guide the needle. 2. High Efficacy ...
Read more

The Future of Cell Culture Media Market Growth, Trends, and Opportunities (2025-2035)

  The global  cell culture media market , valued at $5.2 billion in 2023, is projected to surge to $17.6 billion by 2035, growing at a CAGR of 10.7% from 2024 to 2035. This exponential growth is fueled by rising demand for biopharmaceuticals, vaccines, and gene therapies, driven by increasing cases of cancer, autoimmune disorders, and infectious diseases. Get a Sample Copy of this Report:  https://www.alliedmarketresearch.com/request-sample/A47229
Read more

The Surging Demand for Surgical Masks in India: Trends, Challenges, and Opportunities

  https:// www.alliedmarketresearch.com/surgical-mask-market Surgical masks have become an essential component of healthcare and personal hygiene, playing a crucial role in infection control. In India, the surgical mask market has seen exponential growth, fueled by increased healthcare awareness, rising surgical procedures, and pandemic-induced demand. The market, valued at $71.73 million in 2019, is projected to reach $157.13 million by 2027, growing at a CAGR of 10.3%. Get a Sample Copy of this Report:  https://www.alliedmarketresearch.com/request-sample/5125 Key Growth Drivers 1. Rising Surgical Procedures • India has a high prevalence of infectious diseases, neonatal disorders, and non-communicable diseases, leading to an increased number of surgical interventions. • The growing number of surgeries has directly boosted demand for surgical masks and other disposable protective gear. 2. Increasing Awareness of Hospital-Acquired Infections (HAIs) • HAIs pose a significant thr...
Read more